top of page
Lean Ways To Develop Medicines
Landmark BioVentures AG (LBV), founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company.
LBV takes a unique model focused on lean operations, smart capital allocation, and diversified yet complementary nexus of 7 companies developing 10 first-in-class therapeutics.
Landmark BioVentures Unique Model
Founders & Partners
Bernouillistrasse 20
Basel CH-4056
Switzerland
bottom of page